Skip to main content
Contact Us
Subscribe
E-Edition
75°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Personalis, Inc. - Common Stock
(NQ:
PSNL
)
5.210
+0.150 (+2.96%)
Official Closing Price
Updated: 4:15 PM EDT, Jun 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
June 03, 2025
From
Personalis, Inc.
Via
Business Wire
New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
June 02, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
May 22, 2025
From
Personalis, Inc.
Via
Business Wire
Earnings Scheduled For May 6, 2025
May 06, 2025
Via
Benzinga
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts
February 28, 2025
Via
Benzinga
Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference
May 14, 2025
From
Personalis, Inc.
Via
Business Wire
Analyst Expectations For Personalis's Future
May 07, 2025
Via
Benzinga
Personalis Reports First Quarter 2025 Financial Results
May 06, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
April 28, 2025
From
Personalis, Inc.
Via
Business Wire
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
January 27, 2025
Via
Benzinga
Personalis to Announce First Quarter 2025 Financial Results
April 22, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection
April 22, 2025
From
Personalis, Inc.
Via
Business Wire
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
April 17, 2025
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Via
Investor's Business Daily
What 5 Analyst Ratings Have To Say About Personalis
April 10, 2025
Via
Benzinga
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference
March 26, 2025
From
Personalis, Inc.
Via
Business Wire
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
March 17, 2025
Via
Benzinga
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip
March 08, 2025
Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.
Via
Benzinga
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
March 03, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference
February 18, 2025
From
Personalis, Inc.
Via
Business Wire
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
February 14, 2025
Via
Benzinga
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results
February 13, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2025
From
Personalis, Inc.
Via
Business Wire
New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer
January 13, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue
January 07, 2025
From
Personalis, Inc.
Via
Business Wire
Dow Surges Over 600 Points, Gold Jumps 1.5%
December 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
December 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
December 20, 2024
Via
Benzinga
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
December 20, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.